Related references
Note: Only part of the references are listed.Angiosarcoma: A Tissue Microarray Study With Diagnostic Implications
Priya Rao et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2013)
Selected Protein Monitoring in Histological Sections by Targeted MALDI-FTICR In-Source Decay Imaging
David Calligaris et al.
ANALYTICAL CHEMISTRY (2013)
Cake: a bioinformatics pipeline for the integrated analysis of somatic variants in cancer genomes
Mamunur Rashid et al.
BIOINFORMATICS (2013)
Phylogenetic analysis of multiprobe fluorescence in situ hybridization data from tumor cell populations
Salim Akhter Chowdhury et al.
BIOINFORMATICS (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation
Eunice L. Kwak et al.
CANCER (2013)
MicroRNAs as potential biomarkers in human solid tumors
Jun Shen et al.
CANCER LETTERS (2013)
Transcriptomic responses generated by hepatocarcinogens in a battery of liver-based in vitro models
Tatyana Y. Doktorova et al.
CARCINOGENESIS (2013)
EGFR gets in the way of microRNA biogenesis
Naohiro Nishida et al.
CELL RESEARCH (2013)
Regulating miRNA by Natural Agents as a New Strategy for Cancer Treatment
Sajiv Sethi et al.
CURRENT DRUG TARGETS (2013)
MicroRNAs and Cancer Therapy – From Bystanders to Major Players
Cornelia Braicu et al.
CURRENT MEDICINAL CHEMISTRY (2013)
The Role of 3D Pharmacophore Mapping Based Virtual Screening for Identification of Novel Anticancer Agents: An Overview
Amit K. Halder et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Tissue Metabolomics of Hepatocellular Carcinoma: Tumor Energy Metabolism and the Role of Transcriptomic Classification
Diren Beyoglu et al.
HEPATOLOGY (2013)
MicroRNA Signature Obtained From the Comparison of Aggressive With Indolent Non-Hodgkin Lymphomas: Potential Prognostic Value in Mantle-Cell Lymphoma
Rashmi S. Goswami et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine
Zuanel Diaz et al.
MODERN PATHOLOGY (2013)
Laminin, gamma 2 (LAMC2): A Promising New Putative Pancreatic Cancer Biomarker Identified by Proteomic Analysis of Pancreatic Adenocarcinoma Tissues
Hari Kosanam et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
Noninvasive Monitoring of Pulmonary Fibrosis by Targeting Matrix Metalloproteinases (MMPs)
Yan Cai et al.
MOLECULAR PHARMACEUTICS (2013)
Criteria for the use of omics-based predictors in clinical trials
Lisa M. McShane et al.
NATURE (2013)
Heterogeneity of tumor-induced gene expression changes in the human metabolic network
Jie Hu et al.
NATURE BIOTECHNOLOGY (2013)
Ex vivo culture of human prostate tissue and drug development
Margaret M. Centenera et al.
NATURE REVIEWS UROLOGY (2013)
Bioinformatics analysis of breast cancer bone metastasis related gene-CXCR4
Heng-Wei Zhang et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2013)
Tissue Banking, Bioinformatics, and Electronic Medical Records: The Front-End Requirements for Personalized Medicine
K. Stephen Suh et al.
JOURNAL OF ONCOLOGY (2013)
BreastMark: An Integrated Approach to Mining Publicly Available Transcriptomic Datasets Relating to Breast Cancer Outcome
Stephen F. Madden et al.
BREAST CANCER RESEARCH (2013)
Serine, glycine and one-carbon units: cancer metabolism in full circle
Jason W. Locasale
NATURE REVIEWS CANCER (2013)
Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
Antje Krohn et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Formalin fixation in the -omics' era: a primer for the surgeon-scientist
Adam Frankel
ANZ JOURNAL OF SURGERY (2012)
e-Blood Microscale functional cytomics for studying hematologic cancers
Edmond W. K. Young et al.
BLOOD (2012)
Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer
Robert C. Doebele et al.
CANCER (2012)
TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells
M. R. Moniri et al.
CANCER GENE THERAPY (2012)
Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes
Rui Chen et al.
CELL (2012)
Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non-Small Cell Lung Cancer
Robert C. Doebele et al.
CLINICAL CANCER RESEARCH (2012)
Standardization and Utilization of Biobank Resources in Clinical Protein Science with Examples of Emerging Applications
Gyorgy Marko-Varga et al.
JOURNAL OF PROTEOME RESEARCH (2012)
In vivo models of primary brain tumors: pitfalls and perspectives
Peter C. Huszthy et al.
NEURO-ONCOLOGY (2012)
Functional Screen of Paracrine Signals in Breast Carcinoma Fibroblasts
Gui Su et al.
PLOS ONE (2012)
Fragment-Hopping-Based Discovery of a Novel Chemical Series of Proto-Oncogene PIM-1 Kinase Inhibitors
Gustavo Saluste et al.
PLOS ONE (2012)
Circulating Tumor Cells: Getting More from Less
Joshua M. Lang et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Biobanking: the foundation of personalized medicine
Robert E. Hewitt
CURRENT OPINION IN ONCOLOGY (2011)
Breast cancer - one term, many entities?
Nicholas R. Bertos et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
TRANSLATIONAL MEDICINE Cancer lessons from mice to humans
David Tuveson et al.
NATURE (2011)
Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine
Xu-Yong Sun
World Journal of Stem Cells (2011)
Human prostate cancer heterotransplants: a review on this experimental model
Lluis A. Lopez-Barcons
ASIAN JOURNAL OF ANDROLOGY (2010)
Patient-Derived First Generation Xenografts of Non-Small Cell Lung Cancers: Promising Tools for Predicting Drug Responses for Personalized Chemotherapy
Xin Dong et al.
CLINICAL CANCER RESEARCH (2010)
New concepts of biobanks-strategic chance for uro-oncology
Peter J. Goebell et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
Significance of biological resource collection and tumor tissue bank creation
Ying-Yan Yu et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2010)
Pharmacogenetics and Pharmacogenomics of Anticancer Agents
R. Stephanie Huang et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy
Joshua Z. Press et al.
GYNECOLOGIC ONCOLOGY (2008)
Tracing biological collections - Between books and clinical trials
Francine Kauffmann et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Standard operating procedure for the collection of fresh frozen tissue samples
S. R. Mager et al.
EUROPEAN JOURNAL OF CANCER (2007)
Opinion - Why is cancer drug discovery so difficult?
Alexander Kamb et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: Potential models for studying tumor progression-related changes
Jean-Claude Cutz et al.
CLINICAL CANCER RESEARCH (2006)
Development and characterization of efficient xenograft models for benign and malignant human prostate-tissue
YZ Wang et al.
PROSTATE (2005)
Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models
CH Lee et al.
GYNECOLOGIC ONCOLOGY (2005)
Stromal fibroblasts in cancer initiation and progression
NA Bhowmick et al.
NATURE (2004)
Toxicology and genetic toxicology in the new era of toxicogenomics: impact of -omics technologies
MJ Aardema et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2002)
Share Paper
